5 things to know before the stock market opens on Monday

Happy Monday. I’m not sure what to write for this intro. As someone who is passionate about skin care, I thought I would write this story about the latest men’s beauty trends. But as a Michigan native, it would be remiss of me not to mention it. GMnew headquarters in Detroit.

Stock futures are falling this morning. The stock market is coming off a strong week.

Here are five important things investors need to know to start their trading day.

Federal Reserve Chairman Jerome Powell announced last night that the central bank is under criminal investigation in connection with renovations to the central bank’s buildings. Powell’s statement marks a significant escalation in his conflict with President Donald Trump over the Fed’s stance on interest rates.

Here’s what you need to know:

Powell said in a video statement that federal prosecutors are reviewing the $2.5 billion renovation of the Fed’s headquarters in Washington, D.C., as well as Congressional testimony. “The threat of criminal charges is the result of the Federal Reserve setting interest rates based on its best assessment of what will serve the public, rather than following President Trump’s preferences,” Powell said. Asked about the investigation, President Trump told NBC News last night, “I don’t know anything about it.” Significant interest rate rise. He had previously threatened to fire Powell, and stock futures fell in overnight trading after Powell’s video was released. Gold futures, a safe-haven trade seen as a hedge against the Fed losing its independence, rose. Follow us here for live market updates.

Bank profits will be a top concern for investors this week as they prepare for a new corporate earnings season. However, another notable sector event will take place this month. JP Morgan Chase CEO Jamie Dimon is in his 20th year as CEO.

As CNBC’s Hew Song reports, some are wondering if the executives’ departure marks the end of JPMorgan Chase’s era of dominance. It’s unclear exactly when Dimon plans to step down, but his successor’s timeline is particularly interesting as the CEO approaches his 70th birthday.

JPMorgan will help kick off earnings season tomorrow, followed by peers including: citygroup, morgan stanley and goldman sachs later in the week.

Bank stocks fell sharply in pre-market trading on the day after President Trump said credit card interest rates should be capped at 10% for one year.

walmart and google We are forming a team. Google’s artificial intelligence assistant, Gemini, will help shoppers discover and buy products from retail stores and its warehouse chain Sam’s Club, the companies announced yesterday.

The launch date and financial terms for the new feature are not yet clear, but the plan is to start in the U.S. and then expand internationally. As CNBC’s Melissa Repko points out, Walmart signed a similar deal with Gemini rival OpenAI’s ChatGPT in October.

Google also announced Universal Commerce Protocol yesterday. The company hopes this will become an industry standard among shopping agents who search for and purchase products.

this week, boeing The company is expected to report its highest aircraft deliveries in 2025 since 2018. As CNBC’s Leslie Josephs points out, this is emblematic of the company’s rebuilding efforts after years of reputation-damaging safety crises.

Looking ahead, Boeing plans to expand production of the 737 Max and 787 Dreamliner. Such increases could help the company return to profitability, as Wall Street expects this year.

Speaking of air travel, loyalist Yesterday, it announced that it would acquire a rival low-cost airline. country of the sun in a $1.5 billion deal consisting of cash and stock. The agreement comes as value-focused airlines grapple with rising costs caused by the pandemic.

Blockbuster GLP-1 The market has revolved around weekly injections. But as CNBC’s Annika Kim Constantino reports, obesity drugs could lead to the industry’s next chapter in 2026.

The patient started the first GLP-1 tablet for obesity. novo nordisk Must be taken daily. rival Eli Lilly Similar products are expected to receive regulatory approval within months.

The tablets are not expected to cause further weight loss. But they could be seen as a simpler and perhaps more affordable alternative to the shots, which could in turn expand the market. The pill could bring in new patients who might have been deterred by needles or who thought losing weight wasn’t a priority enough to get weekly injections.

Here’s what we’re looking at this week:

Tuesday: Consumer Price Index. JP Morgan Chase and delta airlines Earnings (before the bell) Wednesday: Producer Price Index. city ​​group, wells fargo Thursday: Morgan Stanley and Goldman Sachs profits (before the bell)

CNBC Pro subscribers can see the calendar and week’s summary here.

CNBC’s Dan Mangan, Yun Li, Hew Song, Sarah Ming, Melissa Repko, Jennifer Elias, Leslie Josephs and Annika Kim Constantino contributed to this report. Terry Cullen edited this version.